Integrating Pharmacogenomic Testing Into a Child Psychiatry Clinic
Public ClinicalTrials.gov record NCT02855580. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to examine the feasibility, acceptability, and utility of pharmacogenomic (PGX) testing (specifically for the cytochrome P450 2D6 and 2C19 genes) prior to initiating treatment with an antidepressant (AD) among children and adolescents in the University of Florida Child Psychiatry clinics.
Study identification
- NCT ID
- NCT02855580
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 71 participants
Conditions and interventions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 8 Years to 20 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2016
- Primary completion
- Jul 5, 2017
- Completion
- Jul 5, 2017
- Last update posted
- Jun 9, 2019
2016 – 2017
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Child Psychiatry Clinic at University of Florida | Gainesville | Florida | 32606 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Obsessive Compulsive Disorder trials
Other public records listing Obsessive Compulsive Disorder. Sorted by last update posted; newest first. Not a recommendation.
- NCT07774481: Anxiety Skills Study Recruiting
- NCT07728994: SONATA LIFU for OCD Recruiting
- NCT06376734: Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness Recruiting
- NCT03313622: Locating Biomarkers in OCD Through Behavioral Tasks Not yet recruiting
- NCT06173752: Mechanisms of Exposure Therapy for OCD Recruiting
- NCT07158801: Project EMPOWER-OCD Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02855580, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 9, 2019 · Synced Sep 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02855580 live on ClinicalTrials.gov.